Sponsor

Academisch Ziekenhuis Maastricht

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Academisch Ziekenhuis Maastricht appears in 13 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials13
Recruiting shown4
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

13 shown
Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PETNCT05654675 · lead sponsor · 2024-01-15
RECRUITING
Southeast Netherlands Advanced Metastatic Breast Cancer RegistryNCT03577197 · lead sponsor · 2007-01-01
RECRUITING
Timely Recovery After Subclinical Heart FailureNCT06341101 · lead sponsor · 2024-03-26
UNKNOWN
Pharmacokinetic Boosting of OsimertinibNCT03858491 · lead sponsor · 2020-11-01
COMPLETED
Light Intensity Physical Activity TrialNCT03415880 · lead sponsor · 2018-11-08
COMPLETED
Various G-CSF Regimens to Prevent Infection During ChemotherapyNCT00536081 · lead sponsor · 2008-01-01
COMPLETED
Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer PatientsNCT07641985 · collaborator · 2026-07-01
RECRUITING
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICINCT04954599 · collaborator · 2023-05-30
RECRUITING
IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II StudyNCT03705403 · collaborator · 2019-04-04
TERMINATED
Echocardiography for RILI PredictionNCT02501707 · collaborator · 2017-04-25
TERMINATED
Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)NCT00850863 · collaborator · 2009-02-01
UNKNOWN
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-RadiationNCT00522639 · collaborator · 2008-10-01
TERMINATED
Phase I Cetuximab and Concurrent Radio-chemotherapyNCT00522886 · collaborator · 2007-04-01
COMPLETED

Drugs studied in this sponsor's trials

5 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Academisch Ziekenhuis Maastricht as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
carboplatin1
cetuximab1
cobicistat1
pegfilgrastim1
perindopril1

Sponsor roles

collaborator7
lead sponsor6
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.